(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13bR)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysen-9-ol

Details

Top
Internal ID 9a52fe63-2ab3-40c8-9107-d586fd922d63
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Triterpenoids
IUPAC Name (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13bR)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-ol
SMILES (Canonical) CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)O)C)CO
SMILES (Isomeric) CC(=C)[C@@H]1CC[C@]2([C@H]1C3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)CO
InChI InChI=1S/C30H50O2/c1-19(2)20-10-15-30(18-31)17-16-28(6)21(25(20)30)8-9-23-27(5)13-12-24(32)26(3,4)22(27)11-14-29(23,28)7/h20-25,31-32H,1,8-18H2,2-7H3/t20-,21?,22-,23+,24-,25+,27-,28+,29+,30+/m0/s1
InChI Key FVWJYYTZTCVBKE-MAIYTPNSSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C30H50O2
Molecular Weight 442.70 g/mol
Exact Mass 442.381080833 g/mol
Topological Polar Surface Area (TPSA) 40.50 Ų
XlogP 8.30
Atomic LogP (AlogP) 7.00
H-Bond Acceptor 2
H-Bond Donor 2
Rotatable Bonds 2

Synonyms

Top
FVWJYYTZTCVBKE-MAIYTPNSSA-N
AKOS025402304
AC-7983
(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13bR)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysen-9-ol

2D Structure

Top
2D Structure of (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13bR)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysen-9-ol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9958 99.58%
Caco-2 - 0.5542 55.42%
Blood Brain Barrier + 0.5750 57.50%
Human oral bioavailability - 0.5857 58.57%
Subcellular localzation Lysosomes 0.4831 48.31%
OATP2B1 inhibitior - 0.7184 71.84%
OATP1B1 inhibitior + 0.9413 94.13%
OATP1B3 inhibitior + 0.9480 94.80%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.6385 63.85%
BSEP inhibitior + 0.6370 63.70%
P-glycoprotein inhibitior - 0.8836 88.36%
P-glycoprotein substrate - 0.7347 73.47%
CYP3A4 substrate + 0.6751 67.51%
CYP2C9 substrate - 0.6284 62.84%
CYP2D6 substrate - 0.7222 72.22%
CYP3A4 inhibition - 0.8309 83.09%
CYP2C9 inhibition - 0.9071 90.71%
CYP2C19 inhibition - 0.9026 90.26%
CYP2D6 inhibition - 0.9297 92.97%
CYP1A2 inhibition - 0.9045 90.45%
CYP2C8 inhibition + 0.4753 47.53%
CYP inhibitory promiscuity - 0.6441 64.41%
UGT catelyzed - 0.5000 50.00%
Carcinogenicity (binary) - 0.9600 96.00%
Carcinogenicity (trinary) Non-required 0.6609 66.09%
Eye corrosion - 0.9892 98.92%
Eye irritation - 0.9008 90.08%
Skin irritation - 0.6073 60.73%
Skin corrosion - 0.9611 96.11%
Ames mutagenesis - 0.7200 72.00%
Human Ether-a-go-go-Related Gene inhibition - 0.3617 36.17%
Micronuclear - 0.9700 97.00%
Hepatotoxicity - 0.8000 80.00%
skin sensitisation - 0.6442 64.42%
Respiratory toxicity + 0.5111 51.11%
Reproductive toxicity + 0.9444 94.44%
Mitochondrial toxicity + 0.9000 90.00%
Nephrotoxicity - 0.7092 70.92%
Acute Oral Toxicity (c) III 0.7441 74.41%
Estrogen receptor binding + 0.8036 80.36%
Androgen receptor binding + 0.7726 77.26%
Thyroid receptor binding + 0.6121 61.21%
Glucocorticoid receptor binding + 0.7877 78.77%
Aromatase binding + 0.6960 69.60%
PPAR gamma - 0.4879 48.79%
Honey bee toxicity - 0.7295 72.95%
Biodegradation - 0.8250 82.50%
Crustacea aquatic toxicity - 0.5600 56.00%
Fish aquatic toxicity + 0.9839 98.39%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
CHEMBL1947 P10828 Thyroid hormone receptor beta-1 3.5 nM
Potency
via Super-PRED

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL218 P21554 Cannabinoid CB1 receptor 95.61% 96.61%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 93.60% 96.09%
CHEMBL233 P35372 Mu opioid receptor 91.49% 97.93%
CHEMBL204 P00734 Thrombin 90.36% 96.01%
CHEMBL253 P34972 Cannabinoid CB2 receptor 89.83% 97.25%
CHEMBL2996 Q05655 Protein kinase C delta 88.72% 97.79%
CHEMBL1994 P08235 Mineralocorticoid receptor 87.86% 100.00%
CHEMBL4482 O96013 Serine/threonine-protein kinase PAK 4 87.32% 95.42%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 87.16% 94.45%
CHEMBL1937 Q92769 Histone deacetylase 2 86.27% 94.75%
CHEMBL241 Q14432 Phosphodiesterase 3A 85.40% 92.94%
CHEMBL2581 P07339 Cathepsin D 85.28% 98.95%
CHEMBL3137262 O60341 LSD1/CoREST complex 85.13% 97.09%
CHEMBL4793 Q86TI2 Dipeptidyl peptidase IX 85.06% 96.95%
CHEMBL5608 Q16288 NT-3 growth factor receptor 84.33% 95.89%
CHEMBL4026 P40763 Signal transducer and activator of transcription 3 84.22% 82.69%
CHEMBL4685 P14902 Indoleamine 2,3-dioxygenase 84.15% 96.38%
CHEMBL2955 O95136 Sphingosine 1-phosphate receptor Edg-5 84.07% 92.86%
CHEMBL4187 Q99250 Sodium channel protein type II alpha subunit 83.71% 95.50%
CHEMBL4040 P28482 MAP kinase ERK2 82.90% 83.82%
CHEMBL3524 P56524 Histone deacetylase 4 82.51% 92.97%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 82.50% 91.11%
CHEMBL2095194 P08709 Coagulation factor VII/tissue factor 80.90% 99.17%
CHEMBL2274 Q9H228 Sphingosine 1-phosphate receptor Edg-8 80.57% 100.00%
CHEMBL206 P03372 Estrogen receptor alpha 80.52% 97.64%
CHEMBL259 P32245 Melanocortin receptor 4 80.20% 95.38%
CHEMBL1966 Q02127 Dihydroorotate dehydrogenase 80.11% 96.09%
CHEMBL237 P41145 Kappa opioid receptor 80.10% 98.10%
CHEMBL4145 Q9UKV0 Histone deacetylase 9 80.00% 85.49%

Cross-Links

Top
PubChem 51340201
NPASS NPC95615